← Insider buys
AKBA

Akebia Therapeutics, Inc. · Healthcare

CEO and President John P. Butler sold $170K of Akebia Therapeutics, Inc.

Sold$169,771
$3.40Price
49,990Shares
−3%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Mon, Mar 1. Filed Tue, Mar 2, 11:10 AM ET, during the session. Not investment advice.